Tag Archives: clinical trials
Sequana Medical receives certification under MDR, the new European Medical Device Regulation
Below, we are re-publishing with permission the press-release issued by Sequana Medical on February 14, 2022 alfapump® is one of the first novel Class III active implantable medical devices to be certified Ghent, Belgium – 14 February 2022 – Sequana Medical NV (Euronext … Continue reading
Clinical Accelerator collaborates with Metavention on a study of a novel medical device for hypertension
Clinical Accelerator and Metavention have recently entered into a collaboration allowing Clinical Accelerator to join the program of feasibility studies already under way in the United States, New Zealand and Australia. Our organization will participate in the renal denervation trial … Continue reading
Replicor publishes its REP 301-LTF study achieving durable functional cure of HDV and HBV, inactivation of cccDNA and elimination of integrated HBV DNA
Below, we are re-publishing with permission the press-release issued by Replicor Inc. on November 16, 2020 MONTREAL, November 16th, 2020 – Replicor Inc., a privately held biopharmaceutical company targeting functional cure for patients with chronic hepatitis B and D infection, … Continue reading
Sequana Medical announces strong interim results from RED DESERT alfapump® DSR study and provides business update
Below, we are re-publishing with permission the press-release issued by Sequana Medical on October 22, 2020 RED DESERT: Results from first five patients indicate repeated dose alfapump DSR therapy to be safe and effective Interim data support DSR hypothesis: kidneys … Continue reading
Posted in Central and Eastern Europe, Clinical Accelerator, Medical Devices
Tagged clinical trials
Leave a comment
Galmed Collaboration Announcement
Clinical Accelerator are very pleased to announce collaboration with Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD), on conducting a phase IIB clinical trial for the treatment of patients with overweight or obesity and who are pre diabetic or type II diabetic with … Continue reading
The importance of study feasibility
With the finances involved and continuing risk of failure, the importance of careful feasibility assessment and judgment is absolute. To what extent weak – or no – feasibility assessment contributes to clinical trial failures is a challenging question. Feasibility study The … Continue reading
clinicalaccelerator.com 
You must be logged in to post a comment.